CLINICAL_TRIALS ClinicalTrials.gov record update

Single-arm, Single-center, Non-randomized, Open-label Study on the Application of Amyloid Imaging Agent [18F]Florbetaben（18FBB） PET/CT Imaging to Distinguish Non-cognitively Impaired Subjects and Mild to Moderate Alzheimer Disease Subjects in Chinese Population

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05527288
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:00.494698+00:00
Published At: 2022-09-02T00:00:00+00:00
Record Updated At: 2022-09-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Alzheimer Disease", "Dementia", "Brain Diseases", "Central Nervous System Diseases", "Nervous System Diseases", "Tauopathies", "Neurodegenerative Diseases", "Neurocognitive Disorders", "Mental Disorders"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-09-02"
protocolSection.identificationModule.nctId: "NCT05527288"
protocolSection.identificationModule.officialTitle: "Single-arm, Single-center, Non-randomized, Open-label Study on the Application of Amyloid Imaging Agent [18F]Florbetaben\uff0818FBB\uff09 PET/CT Imaging to Distinguish Non-cognitively Impaired Subjects and Mild to Moderate Alzheimer Disease Subjects in Chinese Population"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.